Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2007

View Archived Issues

Alefacept active, well tolerated in atopic dermatitis

Good nail penetration results for onychomycosis treatments IVR-101 and IVR-102

Pentavalent human-bovine rotavirus vaccine effective at end of shelf life

Recent Corus patent imparts novel therapeutic agents for chronic obstructive pulmonary disease

New treatments for gastrointestinal disorders claimed in recent patent literature

Novel treatments for musculoskeletal and connective tissue disorders claimed in recent patents

UCB and ImClone terminate CDP-791 agreement

Novel antiviral agents disclosed in recent patent from University of California, Oakland

Novel vanadium complex shows insulin mimetic properties in vivo

Bicyclic monoterpene diol mixture may be useful to repair photodamaged skin

VLA-2: a potential target for the treatment of multiple sclerosis

Jerini and Baxter expand hemophilia research collaboration

Seliciclib to be investigated for nasopharyngeal cancer

Snapshots on preclinical data reported at the 32nd Annual Stroke Conference

Chinese clinical trials confirm XiMingTing's utility in menopausal symptoms

Sciele Pharma licenses fenofibrate/pravastatin combination for mixed dyslipidemia

Migenix updates status of Schering-Plough's license option

Phase II trial of phosphate binder ILY-101 completes enrollment

Avigen reports findings of safety study of AV-411 for neuropathic pain

ATX-MS1467 vaccine cleared for U.K. phase I study in MS

SP-6300 shows potential for Cushing's syndrome

Kallikrein 6 studied as a prognostic marker and a therapeutic target in ovarian cancer

Japanese study supports further evaluation of hypertension chemotherapy

FDA awards orphan drug status to maribavir for CMV viremia and disease

Zingo NDA accepted for filing

Neuroprotective effects of Necrostatin-1 in mice models of ischemic stroke

Sutent approved with new data for advanced renal cell carcinoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...